EVAS2 IDE Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study (EVAS2)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03298477 |
Recruitment Status :
Active, not recruiting
First Posted : October 2, 2017
Last Update Posted : October 1, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Abdominal Aortic Aneurysm Without Rupture | Device: Nellix® System | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 98 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Intervention Model Description: | Prospective, multicenter, single arm study with consecutive, eligible subject enrollment at each site. All subjects will undergo the Endovascular Aneurysm repair procedure with the Nellix System. Sites have been chosen with a suitable research infrastructure and physician experience in endovascular aneurysm repair to ensure adequate enrollment. Subjects will be followed procedurally to discharge, at 30 days (primary safety endpoint), six months, one year (primary effectiveness endpoint) and annually thereafter to five years (total follow-up commitment). |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix System IDE Study (EVAS 2 Confirmatory IDE Study) |
Actual Study Start Date : | December 1, 2017 |
Estimated Primary Completion Date : | August 17, 2022 |
Estimated Study Completion Date : | August 16, 2025 |

Arm | Intervention/treatment |
---|---|
Single Arm
Single Arm Safety and Effectiveness Confirmatory Study of EVAS using the Nellix® System
|
Device: Nellix® System
Endovascular Abdominal Aortic Aneurysm Repair using the Nellix® System |
- Incidence of Major Adverse Events (MAE) [ Time Frame: 30 days ]All cause mortality, bowel ischemia, myocardial infarction, paraplegia, renal failure, respiratory failure, stroke, procedural blood loss >1,000cc
- Rate of Treatment Success [ Time Frame: 1 year ]Procedural technical success and the absence of aneurysm rupture, conversion to open surgical repair, Type I endoleak at 12 months, Type III endoleak at 12 months, aneurysm enlargement, secondary procedure for resolution of endoleak (Type I or III), limb occlusion, migration, aneurysm sac expansion and/or a device defect

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
INCLUSION CRITERIA
A patient who meets all of the following criteria potentially may be included in the study:
- Male or female at least 18 years old;
- Informed consent form understood and signed
- Patient agrees to all follow-up visits;
- Abdominal aortic aneurysm with sac diameter ≥5.0cm, or ≥4.5cm which has increased by ≥0.5cm within the last 6 months, or or which exceeds 1.5 times the transverse dimension of an adjacent non-aneurysmal aortic segment. No AAA <4 cm will be included.
-
Anatomically eligible for the Nellix System (per Instructions For Use):
- Adequate iliac/femoral access compatible with the required delivery systems (diameter ≥6 mm);
- Aneurysm blood lumen diameter ≤60mm;
- Proximal non-aneurysmal aortic neck: length ≥10mm; diameter 18 to 28mm; angle ≤60° to the aneurysm sac;
- Most caudal renal artery to each hypogastric artery length ≥100mm;
- Common iliac artery lumen diameter between 9 and 35mm;
- Distal iliac artery seal zone with length of ≥10mm and diameter range of 9 to 25mm;
- Ability to preserve at least one hypogastric artery.
- Ratio of maximum aortic aneurysm diameter to maximum aortic blood lumen diameter <1.40
EXCLUSION CRITERIA
A patient who meets none of the following criteria potentially may be included in the study:
- Life expectancy <2 years as judged by the Investigator;
- Psychiatric or other condition that may interfere with the study;
- Participating in another clinical study;
- Known allergy or contraindication to any device material;
- Coagulopathy or uncontrolled bleeding disorder;
- Ruptured, leaking or mycotic aneurysm;
- Serum creatinine (S-Cr) level >2.0 mg/dL;
- CVA or MI within three months of enrollment/treatment;
- Aneurysmal disease of the descending thoracic aorta;
- Clinically significant mural thrombus within the proximal landing zone (minimum 10mm) of the infrarenal non-aneurysmal neck (>5mm thickness over >50% circumference);
- Connective tissue diseases (e.g., Marfan Syndrome);
- Unsuitable vascular anatomy that may interfere with device introduction or deployment;
- Pregnant (female of childbearing potential only).

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03298477

Principal Investigator: | Jeffrey Carpenter, MD | Cooper Hospital |
Responsible Party: | Endologix |
ClinicalTrials.gov Identifier: | NCT03298477 |
Other Study ID Numbers: |
CP-0008 EVAS2 IDE |
First Posted: | October 2, 2017 Key Record Dates |
Last Update Posted: | October 1, 2021 |
Last Verified: | September 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | Yes |
Device Product Not Approved or Cleared by U.S. FDA: | Yes |
Aneurysm Aortic Aneurysm Aortic Aneurysm, Abdominal Rupture |
Vascular Diseases Cardiovascular Diseases Aortic Diseases Wounds and Injuries |